| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 03/01/2001 | WO2000072885A9 Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues |
| 03/01/2001 | WO2000071752A3 Assay for the detection of paclitaxel resistant cells in human tumors |
| 03/01/2001 | WO2000071708A3 Use of ef-ts for treating smooth muscle cell hyperplasia |
| 03/01/2001 | WO2000071579A3 Regulating organelle homeostasis in a cell factory |
| 03/01/2001 | WO2000066607A8 Detection using degradation of a tagged sequence |
| 03/01/2001 | WO2000065060A3 Dna sequence and recombinant production of a graminae allergen |
| 03/01/2001 | WO2000065056A3 NUCLEIC ACIDS ENCODING A mutT DOMAIN-CONTAINING POLYPEPTIDE |
| 03/01/2001 | WO2000061190A3 Treatment of intracellular infection |
| 03/01/2001 | WO2000049168A3 Helper adenovirus / helper-dependent adenovirus vector system based on site-specific recombinase activity |
| 03/01/2001 | WO2000049162A8 Compositions and methods for non-targeted activation of endogenous genes |
| 03/01/2001 | WO2000049149A9 Novel tnf receptor-like proteins |
| 03/01/2001 | WO2000049038A3 Synthetic peptide of regulatory virus protein r (vpr) of human immunodeficiency virus type 1 (hiv-1) and the utilization thereof |
| 03/01/2001 | WO2000048638A3 Multi-mutant diphtheria toxin vaccines |
| 03/01/2001 | WO2000029582A8 Cell surface receptor antigen vaccines |
| 03/01/2001 | WO2000029563A8 Nucleic acid isolation |
| 03/01/2001 | WO1999040214A8 Nucleic acid delivery vehicles |
| 03/01/2001 | WO1999036537A3 Fatty acid transport proteins |
| 03/01/2001 | DE19943520A1 Verfahren zur Herstellung eines kanalbildenden Proteins A method for producing a channel-forming protein |
| 03/01/2001 | DE19941448A1 Verfahren zur Herstellung von regelmäßigen Nanostrukturen A process for producing regular nanostructures |
| 03/01/2001 | DE19941239A1 Protease substrate useful for measuring protease activities and in online screening assays for proteases or protease inhibitors, comprises a polypeptide with a binding site, a cleavage site and a stretched helix |
| 03/01/2001 | DE19941186A1 Sequenz-spezifische DNA-Rekombination in eukaryotischen Zellen Sequence-specific DNA recombination in eukaryotic cells |
| 03/01/2001 | DE19940748A1 Arzneimittel enthaltend xenogene Oligo- oder/und Polyribonukleotide Medicament comprising xenogenic oligo- or / and polyribonucleotides |
| 03/01/2001 | DE19940270A1 Preparing plants with increased photosynthetic rate, useful for increasing crop yields, comprises introducing the gene for PsaE subunit of photo-system I |
| 03/01/2001 | DE19937187A1 Automatisierte Proteinreinigung im Multiwellformat durch Vakuumfiltration Automated protein purification in multiwell format by vacuum filtration |
| 03/01/2001 | DE19934718A1 DNA-Sequenzen, die Nodulationsfaktoren kodieren DNA sequences encoding Nodulationsfaktoren |
| 03/01/2001 | DE19933075A1 Nicht-menschliches Säugetier mit gewebespezifisch verändertem Glukokortikoidrezeptor A non-human mammal with a tissue-specific glucocorticoid receptor modified |
| 03/01/2001 | DE10017526A1 Standard protein, useful in protein analysis by e.g. electrophoresis, comprises antibody-binding domain of protein G with at least one amino acid alteration |
| 03/01/2001 | CA2816177A1 Nucleic acid sequences and methods of use for the production of plants with modified polyunsaturated fatty acids |
| 03/01/2001 | CA2589418A1 Human ctla-4 antibodies and their uses |
| 03/01/2001 | CA2383456A1 Pd-1, a receptor for b7-4, and uses therefor |
| 03/01/2001 | CA2383451A1 28-epirapalogs |
| 03/01/2001 | CA2383371A1 P193 proteins and nucleic acids, and uses thereof |
| 03/01/2001 | CA2383074A1 Novel abc transporter and uses thereof |
| 03/01/2001 | CA2383073A1 Compositions and methods for improved cell culture |
| 03/01/2001 | CA2383063A1 Human abc2 transporter and uses thereof |
| 03/01/2001 | CA2382939A1 Method for growing stem cells |
| 03/01/2001 | CA2382820A1 High affinity dna binding compounds as adjuvants in antisense technology |
| 03/01/2001 | CA2382795A1 Homologs of a pneumococcal protein and fragments for vaccines |
| 03/01/2001 | CA2382783A1 A polynucleotide encoding a human junctional adhesion protein (jam-2) |
| 03/01/2001 | CA2382765A1 Sequence derived from a human mammary gland cdna library |
| 03/01/2001 | CA2382693A1 Nucleic acid sequences and methods of use for the production of plants with modified polyunsaturated fatty acids |
| 03/01/2001 | CA2382674A1 Gas1 polypeptides |
| 03/01/2001 | CA2382483A1 Methods and compositions for the construction and use of fusion libraries |
| 03/01/2001 | CA2382468A1 A method for decreasing foam formation during cultivation of trichoderma |
| 03/01/2001 | CA2382462A1 Enzymatic synthesis of deoxyribonucleosides |
| 03/01/2001 | CA2382202A1 Drug conjugates and methods of designing the same |
| 03/01/2001 | CA2382183A1 New g-protein coupled receptor and dna sequences thereof |
| 03/01/2001 | CA2382176A1 Recombinant subunit vaccine |
| 03/01/2001 | CA2382146A1 Pgrp-l polynucleotides, polypeptides, and antibodies |
| 03/01/2001 | CA2382123A1 Novel polynucleotides expressed in activated t-lymphocytes and proteins encoded thereby |
| 03/01/2001 | CA2382101A1 A transmembrane trap for isolating membrane bound proteins |
| 03/01/2001 | CA2382045A1 Hdac4 and hdac5 in the regulation of cardiac gene expression |
| 03/01/2001 | CA2381991A1 Synthetic human papillomavirus genes |
| 03/01/2001 | CA2381969A1 A method for producing quality assured biological sample and composition containing the same |
| 03/01/2001 | CA2381732A1 High sensitivity biomolecule detection with magnetic particles |
| 03/01/2001 | CA2381710A1 D-gluconolactone oxidase gene and method for producing recombinant d-gluconolactone oxidase |
| 03/01/2001 | CA2381206A1 Taq dna polymerases having an amino acid substitution at e681 and homologs thereof exhibiting improved salt tolerance |
| 03/01/2001 | CA2380865A1 Novel response element |
| 03/01/2001 | CA2380457A1 Activatable recombinant neurotoxins |
| 03/01/2001 | CA2379503A1 Simultaneous isolation and quantitation of dna |
| 03/01/2001 | CA2377730A1 Replication protein a binding transcriptional factor (rbt1) and uses thereof |
| 03/01/2001 | CA2376406A1 G protein-coupled receptor expressed in brain |
| 03/01/2001 | CA2376404A1 Meg-1 protein |
| 03/01/2001 | CA2376361A1 Prostate cancer-related gene 3 (pg-3) and biallelic markers thereof |
| 03/01/2001 | CA2376250A1 Peptide and peptide analogues for the treatment and prevention of diabetes |
| 03/01/2001 | CA2348161A1 Process for producing coenzyme q10 |
| 03/01/2001 | CA2347218A1 Novel dna fragment elevating gene expression dose |
| 03/01/2001 | CA2344469A1 Pesticidal proteins |
| 03/01/2001 | CA2317179A1 Macromolecular arrays on polymeric brushes and methods for preparing the same |
| 03/01/2001 | CA2316518A1 Use of ec-sod for treatment of systemic autoimmune diseases |
| 03/01/2001 | CA2315978A1 New nucleotide sequences coding for the thre gene and process for the enzymatic production of l-threonine using coryneform bacteria |
| 03/01/2001 | CA2304453A1 Use of ec-sod for treatment of systemic autoimmune diseases |
| 02/28/2001 | EP1078992A2 Polyclonal and Monoclonal Oligobodies (Synthetic, Oligonucleotide-Based Antibody-Like Reagents), and a method of producing oligobodies |
| 02/28/2001 | EP1078991A2 Methods for producing L-amino acids |
| 02/28/2001 | EP1078989A2 Method for producing L-glutamic acid by fermentation accompanied by precipitation |
| 02/28/2001 | EP1078988A1 Pseudomonas fusion protein vaccines |
| 02/28/2001 | EP1078987A1 Method for examining central nervous system diseases and method for screening remedies |
| 02/28/2001 | EP1078986A2 Secretory thyroid stimulating hormone receptor (TSHR), and method for assaying anti-TSHR antibody using the same |
| 02/28/2001 | EP1078985A2 Map kinase kinases (MEK) |
| 02/28/2001 | EP1078267A1 Assays, methods and means for modulating e2f activity |
| 02/28/2001 | EP1078256A1 Process for evaluating chemical and biological assays |
| 02/28/2001 | EP1078245A1 Instrument for monitoring polymerase chain reaction of dna |
| 02/28/2001 | EP1078104A1 Demonstrating resistance to antibiotics in microorganisms |
| 02/28/2001 | EP1078101A2 Solution hybridization of nucleic acids with antisense probes having modified backbones |
| 02/28/2001 | EP1078098A1 Method and probes for the detection of chromosome aberrations |
| 02/28/2001 | EP1078097A1 Cell-free chimeraplasty and eukaryotic use of heteroduplex mutational vectors |
| 02/28/2001 | EP1078096A1 Multiviral compositions and uses thereof |
| 02/28/2001 | EP1078095A1 Viral production process |
| 02/28/2001 | EP1078094A1 Methods and compositions for producing viral particles |
| 02/28/2001 | EP1078093A1 Vaccines, immunotherapeutics and methods for using the same |
| 02/28/2001 | EP1078092A2 Expression vectors for stimulating an immune response and methods of using the same |
| 02/28/2001 | EP1078091A2 Gene therapy vectors and their use in antitumour therapy |
| 02/28/2001 | EP1078090A1 Disease resistant transgenic plants |
| 02/28/2001 | EP1078089A2 Method for producing plants having an increased tolerance against drought and/or fungal attack and/or increased salt concentrations and/or extreme temperature by the expression of plasmodesmata-localized proteins |
| 02/28/2001 | EP1078088A2 Transgenic plants with a modified activity of a plastidial adp/atp translocator |
| 02/28/2001 | EP1078087A2 Zea mays phosphate transporter genes and uses thereof |
| 02/28/2001 | EP1078086A2 Plant-derived resistance gene |
| 02/28/2001 | EP1078085A1 Use of a polypeptide derived from a pa1b legume albumen as insecticide |
| 02/28/2001 | EP1078084A1 Method of producing plants which are tolerant or resistant to herbicides |
| 02/28/2001 | EP1078083A1 Genes and methods for control of nematodes in plants |